Research context
KPV is shorthand for the lysine-proline-valine sequence. It names a component; the 10 mg amount defines neither an experimental protocol nor a human dose.
Primary PepT1-related research reports cell and animal-model observations. Model findings are not generalized into clinical benefit or efficacy of this catalog product.
Batch-specific identity, purity, stability and sterility data for MT Peptides have not yet been provided. General scientific publications are not a certificate of analysis for this product.
